|1.||Ohtsu, Hiroshi: 41 articles (11/2015 - 06/2002)|
|2.||Chen, Zhong: 40 articles (05/2015 - 01/2002)|
|3.||Kamei, Chiaki: 27 articles (10/2013 - 04/2002)|
|4.||Thurmond, Robin L: 24 articles (09/2015 - 11/2004)|
|5.||Watanabe, Takeshi: 21 articles (01/2015 - 04/2002)|
|6.||Falus, A: 20 articles (08/2012 - 02/2000)|
|7.||Leurs, Rob: 19 articles (09/2013 - 06/2003)|
|8.||Yanai, Kazuhiko: 18 articles (12/2013 - 01/2002)|
|9.||Fukui, Hiroyuki: 18 articles (04/2012 - 10/2003)|
|10.||Hellstrand, Kristoffer: 16 articles (05/2015 - 01/2002)|
|1.||Asthma (Bronchial Asthma)
01/01/2010 - "Patients with a former diagnosis of asthma and a positive histamine provocation test were re-examined to identify subjects with complete asthma remission (no asthma symptoms or medication, PC20 histamine > 32 mg/ml, FEV1 > 90% predicted). "
03/01/1984 - "is a bronchodilator in asthmatics and ameliorates histamine induced bronchoconstriction has important implications for the pharmacology of asthma."
08/01/2011 - "Three RCTs and one NRCT suggested that yoga leads to a significantly greater reduction in spirometric measures, airway hyperresponsivity, dose of histamine needed to provoke a 20% reduction in forced expiratory volume in the first second, weekly number of asthma attacks, and need for drug treatment. "
03/01/1992 - "Although there was no significant relationship between the severity of asthma and respiratory threshold to histamine (RT-Hist) at the initial test, RT-Hist results in the severely asthmatic group were significantly lower than those of the remission and mild groups at the final test (P less than .01), respectively. "
03/01/1988 - "The histamine concentration of the baseline lavage samples (bronchoalveolar lavage and isolated airway segment lavage) for the subjects with asthma were significantly greater than for the atopic or normal subjects (p less than 0.05). "
05/01/2000 - "Recent studies suggest that histamine H2-receptor antagonists may be useful in the treatment of urticaria. "
01/01/1989 - "These results suggest that alpha-FMH may be useful in the treatment of severe cold urticaria especially in combination with histamine exhaustion of mast cells using cold water."
11/01/2009 - "As for urticaria, the use of oral histamine H1-receptor antagonists is the first line treatment, regardless of the groups, provided that sufficient efforts to eliminate the cause and/or aggravating factors are taken. "
11/01/1990 - "These findings demonstrate a prolongation of skin responses to histamine in patients with urticaria and suggest an impaired clearance of histamine (or other vasoactive agents released by histamine) from the skin of these patients."
03/01/2011 - "Most studies have used histamine release assays rather than autologous serum skin tests (ASSTs) for correlating urticaria severity and histamine releasing activity. "
06/01/1998 - "Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis."
01/01/1994 - "The results of our investigation demonstrated that histamine might cause the number of CD4 and CD8 cells into disorder in allergic nasal mucosal epithelium and the H2 antagonist may be useful in the treatment of allergic rhinitis."
01/01/1988 - "[Comparison of the efficacy of two H2 antagonists of histamine in allergic rhinitis. "
01/01/2014 - "Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit."
11/01/2011 - "The present study was designed to investigate CBF in the acute phase of allergic rhinitis and the effect of histamine on CBF. "
01/01/1993 - "Serum histamine levels have been shown to be elevated in CRF patients with itching, and ultraviolet B (UVB) therapy, even if applied to only part of the body surface, has been reported to be beneficial for the generalized relief of the pruritus. "
07/01/2014 - "The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects."
07/01/2014 - "In conclusion, JNJ 39758979 was effective in inhibiting histamine-induced pruritus in healthy subjects. "
07/01/2014 - "A clinical study was conducted to evaluate the safety and efficacy of the H4R antagonist, JNJ 39758979 [(R)-4-(3-amino-pyrrolidin-1-yl)-6-isopropyl-pyrimidin-2-ylamine], on histamine-induced pruritus in healthy subjects. "
01/01/1985 - "Placebo-controlled study of the efficacy of topical antihistaminics against histamine-induced pruritus."
04/01/2008 - "sapida (75 mg/kg, p.o., for 7 days) showed significant protection against histamine aerosol induced bronchospasm. "
01/01/2008 - "All the test compounds exhibited good protection against histamine-induced bronchospasm. "
01/01/1988 - "However, histamine H1-antagonists produce significant protection against bronchospasms which are induced experimentally by a variety of conditions in asthmatic patients. "
12/01/1982 - "A greater loss of protection against histamine-induced bronchospasm was seen in asthmatics than in normals (approximately twofold), although the difference was not significant. "
01/01/1966 - "[Studies with experimental bronchospasm (histamine provocation test) for determination of the efficacy of an antihistaminic]."
|2.||Histamine Antagonists (Antihistamines)
|3.||Serotonin (5 Hydroxytryptamine)
|4.||Acetylcholine (Acetylcholine Chloride)
|7.||Immunoglobulin E (IgE)